Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-24-000029

General Counsel and CCO acquired 95,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Naftzger J. Christopher · General Counsel and CCO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-01 Grant or award : show line 1 in the form +95,100 95,100 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +380,500 380,500 D
Loading xslF345X05/wk-form4_1707180904.xml…